Topical paromomycin for New World cutaneous leishmaniasis

BACKGROUND: Paromomycin-based topical treatments were shown to be effective in curing cutaneous leishmaniasis (CL) lesions caused by Leishmania major in Tunisia. Cure rates of an index lesion were approximately 80%. As a follow on, we conducted a similar Phase 3 trial in Panama to demonstrate the ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS Negl Trop Dis
Main Authors: Sosa, Néstor, Pascale, Juan Miguel, Jiménez, Ana I., Norwood, Jeanne A., Kreishman-Detrick, Mara, Weina, Peter J., Lawrence, Kendra, McCarthy, William F., Adams, Ryan C., Scott, Charles, Ransom, Janet, Tang, Douglas, Grogl, Max
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6497224/
https://ncbi.nlm.nih.gov/pubmed/31048871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0007253
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados